✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Alnylam Pharmaceuticals Inc

Common Name
Alnylam Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
2,500
Ticker
ALNY
Exchange
NASDAQ/NGS
Description
Alnylam Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing RNA interference (RNAi) therapeutics. This innovative gene silencing technology targets the root ca...

Alnylam Pharmaceuticals's Water Management Data

Explore Alnylam Pharmaceuticals's corporate water use and management data, including total water withdrawal, consumption, discharge, recycling, and reuse trends over time.

Metric (m³)2025202420232022-2019
Total Water Withdrawn
100,605a
109,106a
136,383a
Total Water Consumed
30,322a
59,099a
68,191a
Total Water Discharged
70,283a
45,461a
68,191a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Alnylam Pharmaceuticals’s Water Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Alnylam Pharmaceuticals's Corporate Responsibility Report (CRR) 2025